{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:56:00Z","timestamp":1793199360980,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cell therapy using intramuscular injections of autologous bone-marrow mononuclear cells (BM-MNCs) improves clinical symptoms and can prevent limb amputation in atherosclerotic peripheral arterial disease (PAD) patients with critical limb ischemia (CLI). The purpose of this study was to evaluate the effects of the number of implanted BM-MNCs on clinical outcomes in atherosclerotic PAD patients with CLI who underwent cell therapy. This study was a retrospective observational study with median follow-up period of 13.5\u00a0years (range, 6.8\u201315.5\u00a0years) from BM-MNC implantation procedure. The mean number of implanted cells was 1.2\u2009\u00b1\u20090.7\u2009\u00d7\u200910<jats:sup>9<\/jats:sup> per limb. There was no significant difference in number of BM-MNCs implanted between the no major amputation group and major amputation group (1.1\u2009\u00b1\u20090.7\u2009\u00d7\u200910<jats:sup>9<\/jats:sup> vs. 1.5\u2009\u00b1\u20090.8\u2009\u00d7\u200910<jats:sup>9<\/jats:sup> per limb, P\u2009=\u20090.138). There was also no significant difference in number of BM-MNCs implanted between the no death group and death group (1.5\u2009\u00b1\u20090.9\u2009\u00d7\u200910<jats:sup>9<\/jats:sup> vs. 1.8\u2009\u00b1\u20090.8\u2009\u00d7\u200910<jats:sup>9<\/jats:sup> per patient, P\u2009=\u20090.404). Differences in the number of BM-MNCs (mean number, 1.2\u2009\u00b1\u20090.7\u2009\u00d7\u200910<jats:sup>9<\/jats:sup> per limb) for cell therapy did not alter the major amputation-free survival rate or mortality rate in atherosclerotic PAD patients with CLI. A large number of BM-MNCs will not improve limb salvage outcome or mortality.<\/jats:p>","DOI":"10.1038\/s41598-020-76886-6","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T11:04:49Z","timestamp":1605524689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Relationship between cell number and clinical outcomes of autologous bone-marrow mononuclear cell implantation in critical limb ischemia"],"prefix":"10.1038","volume":"10","author":[{"given":"Farina Mohamad","family":"Yusoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Kajikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Takaeko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Maruhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Fadilah S. Abdul","family":"Wahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihito","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"key":"76886_CR1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","volume":"382","author":"FG Fowkes","year":"2013","unstructured":"Fowkes, F. G. et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382, 1329\u20131340. https:\/\/doi.org\/10.1016\/S0140-6736(13)61249-0 (2013).","journal-title":"Lancet"},{"key":"76886_CR2","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.1038\/s41598-017-06597-y","volume":"7","author":"Y Higashi","year":"2017","unstructured":"Higashi, Y. et al. Two-year follow-up of vascular events in peripheral arterial disease treated with antiplatelet agents: a prospective observational multicenter cohort study (SEASON). Sci. Rep. 7, 6095. https:\/\/doi.org\/10.1038\/s41598-017-06597-y (2017).","journal-title":"Sci. Rep."},{"issue":"Suppl 1","key":"76886_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejvs.2006.09.024","volume":"33","author":"L Norgren","year":"2007","unstructured":"Norgren, L. et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J. Vasc. Endovasc. Surg. 33(Suppl 1), 1\u201375. https:\/\/doi.org\/10.1016\/j.ejvs.2006.09.024 (2007).","journal-title":"Eur J. Vasc. Endovasc. Surg."},{"key":"76886_CR4","first-page":"499","volume":"21","author":"R Fontaine","year":"1954","unstructured":"Fontaine, R., Kim, M. & Kieny, R. Surgical treatment of peripheral circulation disorders. Helv. Chir Acta. 21, 499\u2013533 (1954).","journal-title":"Helv. Chir Acta."},{"key":"76886_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","volume":"26","author":"RB Rutherford","year":"1997","unstructured":"Rutherford, R. B. et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J. Vasc. Surg. 26, 517\u2013538 (1997).","journal-title":"J. Vasc. Surg."},{"key":"76886_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jvs.2013.08.003","volume":"59","author":"JL Mills Sr","year":"2014","unstructured":"Mills, J. L. Sr. et al. The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J. Vasc. Surg. 59, 220\u2013234. https:\/\/doi.org\/10.1016\/j.jvs.2013.08.003 (2014).","journal-title":"J. Vasc. Surg."},{"key":"76886_CR7","doi-asserted-by":"publisher","first-page":"e002938","DOI":"10.1161\/JAHA.115.002938","volume":"5","author":"M Teraa","year":"2016","unstructured":"Teraa, M., Conte, M. S., Moll, F. L. & Verhaar, M. C. Critical limb ischemia: current trends and future directions. J. Am. Heart Assoc. 5, e002938. https:\/\/doi.org\/10.1161\/JAHA.115.002938 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"76886_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","volume":"360","author":"E Tateishi-Yuyama","year":"2002","unstructured":"Tateishi-Yuyama, E. et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. The Lancet 360, 427\u2013435. https:\/\/doi.org\/10.1016\/S0140-6736(02)09670-8 (2002).","journal-title":"The Lancet"},{"key":"76886_CR9","doi-asserted-by":"publisher","unstructured":"Matoba, S. et al. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J. 156, 1010\u20131018. https:\/\/doi.org\/10.1016\/j.ahj.2008.06.025 (2008).","DOI":"10.1016\/j.ahj.2008.06.025"},{"key":"76886_CR10","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.jvs.2016.01.022","volume":"63","author":"TW Liang","year":"2016","unstructured":"Liang, T. W. et al. Autologous bone marrow mononuclear cell therapy for critical limb ischemia is effective and durable. J. Vasc. Surg. 63, 1541\u20131545. https:\/\/doi.org\/10.1016\/j.jvs.2016.01.022 (2016).","journal-title":"J. Vasc. Surg."},{"key":"76886_CR11","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1038\/s41598-019-44176-5","volume":"9","author":"FM Yusoff","year":"2019","unstructured":"Yusoff, F. M. et al. Review of the long-term effects of autologous bone-marrow mononuclear cell implantation on clinical outcomes in patients with critical limb ischemia. Sci. Rep. 9, 7711. https:\/\/doi.org\/10.1038\/s41598-019-44176-5 (2019).","journal-title":"Sci. Rep."},{"key":"76886_CR12","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1253\/circj.CJ-17-0045","volume":"81","author":"B Pignon","year":"2017","unstructured":"Pignon, B. et al. Autologous bone marrow mononuclear cell implantation and its impact on the outcome of patients with critical limb ischemia: results of a randomized, double-blind, placebo-controlled trial. Circ. J. 81, 1713\u20131720. https:\/\/doi.org\/10.1253\/circj.CJ-17-0045 (2017).","journal-title":"Circ. J."},{"key":"76886_CR13","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.jvs.2009.07.113","volume":"50","author":"RW Franz","year":"2009","unstructured":"Franz, R. W. Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease. J. Vasc. Surg. 50, 1378\u20131390. https:\/\/doi.org\/10.1016\/j.jvs.2009.07.113 (2009).","journal-title":"J. Vasc. Surg."},{"key":"76886_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/stem.2751","volume":"36","author":"M Qadura","year":"2018","unstructured":"Qadura, M., Terenzi, D. C., Verma, S., Al-Omran, M. & Hess, D. A. Concise review: cell therapy for critical limb ischemia: an integrated review of preclinical and clinical studies. Stem Cells. 36, 161\u2013171. https:\/\/doi.org\/10.1002\/stem.2751 (2018).","journal-title":"Stem Cells."},{"key":"76886_CR15","doi-asserted-by":"publisher","unstructured":"Abdul Wahid,\u00a0S. F. et al. Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients. Cochrane\u00a0Database Syst Rev. 29, 8: CD010747, https:\/\/doi.org\/https:\/\/doi.org\/10.1002\/14651858.CD010747.pub2 (2018).","DOI":"10.1002\/14651858.CD010747.pub2"},{"key":"76886_CR16","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.116.309045","volume":"120","author":"M Rigato","year":"2017","unstructured":"Rigato, M., Monami, M. & Fadini, G. P. Autologous cell therapy for peripheral arterial disease: systematic review and meta-analysis of randomized, nonrandomized, and noncontrolled studies. Circ. Res. 120, 1326\u20131340. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309045 (2017).","journal-title":"Circ. Res."},{"key":"76886_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.08.033","volume":"209","author":"GP Fadini","year":"2010","unstructured":"Fadini, G. P., Agostini, C. & Avogaro, A. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis 209, 10\u201317. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.08.033 (2010).","journal-title":"Atherosclerosis"},{"key":"76886_CR18","volume-title":"Therapeutics angiogenesis","year":"2017","unstructured":"Higashi, Y. & Murohara, T. (eds) Therapeutics angiogenesis (Springer Nature, Berlin, 2017)."},{"key":"76886_CR19","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1253\/circj.CJ-17-0510","volume":"82","author":"K Kondo","year":"2018","unstructured":"Kondo, K. et al. Long-term clinical outcomes survey of bone marrow-derived cell therapy in critical limb ischemia in Japan. Circ. J 82, 1168\u20131178. https:\/\/doi.org\/10.1253\/circj.CJ-17-0510 (2018).","journal-title":"Circ. J"},{"key":"76886_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/CIRCINTERVENTIONS.110.955724","volume":"4","author":"N Idei","year":"2011","unstructured":"Idei, N. et al. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and buerger disease. Circ. Cardiovasc. Interv. 4, 15\u201325. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.110.955724 (2011).","journal-title":"Circ. Cardiovasc. Interv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76886-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76886-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76886-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T23:18:47Z","timestamp":1670368727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-76886-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["76886"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-76886-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,16]]},"assertion":[{"value":"8 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19891"}}